Proposed USPTO Limits to Continuing Examinations, Claims May Hinder Life Sciences Patent Process
This article was originally published in The Pink Sheet Daily
Executive Summary
Two proposals intended to trim the backlog of applications reviewed by the U.S. Patent and Trademark Office could adversely affect life sciences applicants, some patent lawyers contend.